Status:

TERMINATED

Role of microRNA in the Development of Cutaneous Squamous Cell Carcinoma

Lead Sponsor:

Centre Hospitalier Universitaire de Nice

Conditions:

Cancer of the Skin

Eligibility:

All Genders

40+ years

Phase:

NA

Brief Summary

The aim of this study is to analyze the differential expression of the miR transcriptome in the distinctive stages of the development of cutaneous squamous cell carcinoma (C-SCC). In this aim the inve...

Eligibility Criteria

Inclusion

  • patient older than 40th, suffering of a C-SCC
  • letter of consent signed by the patient
  • to be registered to social security

Exclusion

  • Pregnant women or breastfeeding.
  • Small C-SCC (size \< 6mm)
  • Allergy to Xylocaine
  • All vulnerable (minor, adult guardianship…)

Key Trial Info

Start Date :

June 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2011

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT01143311

Start Date

June 1 2010

End Date

April 1 2011

Last Update

June 1 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU de Nice - 4 avenue Reine Victoria - Hôpital de Cimiez

Nice, Alpes-Maritimes, France, 06001

Role of microRNA in the Development of Cutaneous Squamous Cell Carcinoma | DecenTrialz